SLC19A3 and Leigh syndrome: Moreover, early supplementation with both thiamine and biotin in patients with LS caused by a mutation in SLC19A3, a gene essential to thiamine transporter-2 deficiency, has been found to have an immediate therapeutic effect [118,119].